Investigation Overview
April 27, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Heron Therapeutics Inc (NASDAQ:HRTX) was announced over potential breaches of fiduciary duties by certain officers and directors at Heron Therapeutics. The investigation by a law firm concerns whether certain Heron Therapeutics officers and directors breached their fiduci...
You must register (for free) or login to view the entire investigation.